{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T11:30:52Z","timestamp":1772796652795,"version":"3.50.1"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2007,8,29]],"date-time":"2007-08-29T00:00:00Z","timestamp":1188345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,8,29]],"date-time":"2007-08-29T00:00:00Z","timestamp":1188345600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Atheroscler Rep"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1007\/s11883-007-0048-x","type":"journal-article","created":{"date-parts":[[2007,8,28]],"date-time":"2007-08-28T11:51:53Z","timestamp":1188301913000},"page":"375-383","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Should hyperhomocysteinemia be treated in patients with atherosclerotic disease?"],"prefix":"10.1007","volume":"9","author":[{"given":"Bradley A.","family":"Maron","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Loscalzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,8,29]]},"reference":[{"issue":"Suppl2","key":"48_CR1","first-page":"S25","volume":"3","author":"S.R. Deitcher","year":"2002","unstructured":"Deitcher SR, Jaff MR: Pharmacologic and clinical characteristics of thrombolytic agents. Rev Cardiovasc Med 2002, 3(Suppl 2):S25\u201333.","journal-title":"Rev Cardiovasc Med"},{"key":"48_CR2","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1161\/hc4601.099487","volume":"104","author":"S. Yusuf","year":"2001","unstructured":"Yusuf S, Reddy S, Ounpuu S, Anand S: Global burden of cardiovascular disease, I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 2001, 104:2746\u20132753.","journal-title":"Circulation"},{"key":"48_CR3","first-page":"489","volume":"30","author":"Coronary Drug Project Research Group","year":"1978","unstructured":"Coronary Drug Project Research Group: Natural history of myocardial infarction in the coronary drug project: long term implications of serum lipid levels. Am J Cardiol 1978, 30:489\u2013498.","journal-title":"Am J Cardiol"},{"key":"48_CR4","doi-asserted-by":"crossref","unstructured":"The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA 1984, 251:365\u2013374.","DOI":"10.1001\/jama.251.3.365"},{"key":"48_CR5","first-page":"111","volume":"56","author":"K.S. McCully","year":"1969","unstructured":"McCully KS: Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol 1969, 56:111\u2013128.","journal-title":"Am J Pathol"},{"key":"48_CR6","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1001\/jama.274.13.1049","volume":"274","author":"C.J. Boushey","year":"1995","unstructured":"Boushey CJ, Beresford SA, Omenn GS, Motulsky AG: A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 1995, 274:1049\u20131057.","journal-title":"JAMA"},{"key":"48_CR7","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1056\/NEJMoa060900","volume":"354","author":"E. Lonn","year":"2006","unstructured":"Lonn E, Yusuf S, Arnold MJ, et al.: Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 2006, 354:1567\u20131577.","journal-title":"N Engl J Med"},{"key":"48_CR8","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1056\/NEJMoa055227","volume":"354","author":"K.H. B\u00f8nna","year":"2006","unstructured":"B\u00f8nna KH, Njolstad I, Ueland PM, et al.: Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 2006, 354:1578\u20131588.","journal-title":"N Engl J Med"},{"key":"48_CR9","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1001\/jama.291.5.565","volume":"291","author":"J.F. Toole","year":"2004","unstructured":"Toole JF, Malinow MR, Chambless LE, et al.: Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the vitamin intervention for stroke prevention (VISP) randomized controlled trial. JAMA 2004, 291:565\u2013575.","journal-title":"JAMA"},{"key":"48_CR10","first-page":"248","volume-title":"Lippincott\u2019s Illustrated Reviews: Biochemistry","author":"P. Champe","year":"1987","unstructured":"Champe P, Harvey R: Amino acids: metabolism of carbon skeletons. In Lippincott\u2019s Illustrated Reviews: Biochemistry, 2nd edition. Edited by Champe P, Harvey R. Philadelphia: JB Lippincott; 1987:248\u2013249.","edition":"2nd edition"},{"key":"48_CR11","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/0955-2863(90)90070-2","volume":"1","author":"J.D. Finkelstein","year":"1990","unstructured":"Finkelstein JD: Methionine metabolism in mammals. J Nutr Biochem 1990, 1:228\u2013237.","journal-title":"J Nutr Biochem"},{"key":"48_CR12","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1161\/01.CIR.99.1.178","volume":"99","author":"R. Malinow","year":"1999","unstructured":"Malinow R, Bostom AG, Krauss RM: Homocyst(e)ine, diet, and cardiovascular diseases: a statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation 1999, 99:178\u2013182.","journal-title":"Circulation"},{"key":"48_CR13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1161\/01.CIR.93.1.7","volume":"93","author":"P.F. Jacques","year":"1996","unstructured":"Jacques PF, Bostom AG, Williams RR, et al.: Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 1996, 93:7\u20139.","journal-title":"Circulation"},{"key":"48_CR14","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1161\/01.CIR.98.23.2520","volume":"98","author":"L. Brattstrom","year":"1998","unstructured":"Brattstrom L, Wilcken DE, Ohrvik J, et al.: Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis. Circulation 1998, 98:2520\u20132256.","journal-title":"Circulation"},{"key":"48_CR15","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.amjcard.2004.02.009","volume":"93","author":"K. Kolling","year":"2004","unstructured":"Kolling K, Ndrepepa G, Koch W, et al.: Methylenetetrahydrofolate reductase gene C677T and A1298C polymorphisms, plasma homocysteine, folate, and vitamin B12 levels and the extent of coronary artery disease. Am J Cardiol 2004, 93:1201\u20131206.","journal-title":"Am J Cardiol"},{"key":"48_CR16","first-page":"395","volume":"15","author":"V. Garovic-Kocic","year":"1995","unstructured":"Garovic-Kocic V, Rosenblatt DS: Methionine auxotrophy in inborn errors of cobalamin metabolism. Clin Invest Med 1995, 15:395\u2013400.","journal-title":"Clin Invest Med"},{"key":"48_CR17","first-page":"223","volume-title":"Homocysteine in Health and Disease","author":"J.P. Kraus","year":"2001","unstructured":"Kraus JP, Kozich V: Cystathionine b-synthase and its deficiency. In Homocysteine in Health and Disease. Edited by Carmel R, Jacobsen DW. New York: Cambridge University Press; 2001:223\u2013244."},{"key":"48_CR18","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1073\/pnas.92.5.1585","volume":"92","author":"M. Watanabe","year":"1995","unstructured":"Watanabe M, Osada J, Aratani Y, et al.: Mice deficient in cystathionine beta-synthase: animal models for mild and severe homocyst(e)inemia. Proc Natl Acad Sci U S A 1995, 92:1585\u20131589.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"48_CR19","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1172\/JCI8342","volume":"106","author":"R.T. Eberhardt","year":"2000","unstructured":"Eberhardt RT, Fogione MA, Cap A, et al.: Endothelial dysfunction in a murine model of mild hyperhomocyst(e)inemia. J Clin Invest 2000, 106:483\u2013491.","journal-title":"J Clin Invest"},{"key":"48_CR20","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1093\/jn\/134.11.2975","volume":"134","author":"H. Ghandour","year":"2004","unstructured":"Ghandour H, Chen Z, Selhub J, et al.: Mice deficient in methylenetetrahydrofolate reductase exhibit tissue-specific distribution of folates. J Nutr 2004, 134:2975\u20132980.","journal-title":"J Nutr"},{"key":"48_CR21","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/hmg\/10.5.433","volume":"10","author":"Z. Chen","year":"2001","unstructured":"Chen Z, Karaplis AC, Ackerman SL, et al.: Mice deficient in methylenetetrahydrofolate reductase exhibit hyperhomocysteinemia and decreased methylation capacity, with neuropathology and aortic lipid deposition. Hum Mol Genet 2001, 10:433\u2013443.","journal-title":"Hum Mol Genet"},{"key":"48_CR22","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.cll.2006.06.008","volume":"26","author":"B.A. Maron","year":"2006","unstructured":"Maron BA, Loscalzo J: Homocysteine. Clin Lab Med 2006, 26:591\u2013609.","journal-title":"Clin Lab Med"},{"key":"48_CR23","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1055\/s-0037-1613105","volume":"87","author":"A. Tropodi","year":"2002","unstructured":"Tropodi A, Chantarangkul V, Lombardi R, et al.: Multicenter study of homocysteine measurement\u2014performance characteristics of different methods, influence of standards on interlaboratory agreement of results. Thromb Haemost 2002, 87:921\u2013922.","journal-title":"Thromb Haemost"},{"key":"48_CR24","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1309\/0F85-MTU8-KL3D-7JJP","volume":"124","author":"E. Mourvaki","year":"2005","unstructured":"Mourvaki E, Ferrante F, Chirarduzzi A, et al.: Performance comparison of three assay methods used in fasting and postmethionine load plasma homocysteine determinations from patients with vascular disease. Am J Clin Pathol 2005, 124:675\u2013681.","journal-title":"Am J Clin Pathol"},{"issue":"Suppl12","key":"48_CR25","first-page":"16","volume":"9","author":"R.N. Foley","year":"1998","unstructured":"Foley RN, Parfrey PS, Sarnak MJ: Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 1998, 9(Suppl 12):16\u201323.","journal-title":"J Am Soc Nephrol"},{"key":"48_CR26","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1373\/clinchem.2003.021634","volume":"50","author":"H. Refsum","year":"2004","unstructured":"Refsum H, Smith D, Ueland P, et al.: Facts and recommendations about total homocysteine determinations: an expert opinion. Clin Chem 2004, 50:3\u201332.","journal-title":"Clin Chem"},{"key":"48_CR27","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1191\/1358863x02vm428ra","volume":"7","author":"N. Weiss","year":"2003","unstructured":"Weiss N, Keller C, Hoffmann U, Loscalzo J: Endothelial dysfunction and atherothrombosis in mild hyperhomocysteinemia. Vasc Med 2003, 7:227\u2013239.","journal-title":"Vasc Med"},{"issue":"48Suppl9","key":"48_CR28","doi-asserted-by":"publisher","first-page":"A33","DOI":"10.1016\/j.jacc.2006.08.011","volume":"7","author":"P. Libby","year":"2006","unstructured":"Libby P, Ridker PM: Inflammation and atherothrombosis from population biology and bench research to clinical practice. J Am Coll Cardiol 2006, 7:48(Suppl 9):A33\u201346.","journal-title":"J Am Coll Cardiol"},{"key":"48_CR29","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/nature01323","volume":"420","author":"P. Libby","year":"2002","unstructured":"Libby P: Inflammation in atherosclerosis. Nature 2002, 420:868\u2013874.","journal-title":"Nature"},{"key":"48_CR30","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1161\/01.CIR.0000038140.80105.AD","volume":"19","author":"S. Inoue","year":"2002","unstructured":"Inoue S, Egashira K, Ni W, et al.: Anti-monocyte chemoattractant protein-1 gene therapy limits progression and destabilization of established atherosclerosis in apolipoprotein E-knockout mice. Circulation 2002, 19:2700\u20132706.","journal-title":"Circulation"},{"key":"48_CR31","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1161\/hc5001.100631","volume":"104","author":"X.H. Xu","year":"2001","unstructured":"Xu XH, Shah PK, Faure E, et al.: Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL. Circulation 2001, 104:3103\u20133108.","journal-title":"Circulation"},{"key":"48_CR32","doi-asserted-by":"publisher","first-page":"H852","DOI":"10.1152\/ajpheart.00015.2005","volume":"289","author":"J.W. Zmijewski","year":"2005","unstructured":"Zmijewski JW, Moellering DR, Le Goffe C, et al.: Oxidized LDL induces mitochondrially associated reactive oxygen\/nitrogen species formation in endothelial cells. Am J Physiol Heart Circ Physiol 2005, 289:H852\u2013861.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"48_CR33","doi-asserted-by":"publisher","first-page":"14214","DOI":"10.1074\/jbc.270.23.14214","volume":"270","author":"H.B. Peng","year":"1995","unstructured":"Peng HB, Libby P, Liao JK: Induction and stabilization of I kappa B alpha by nitric oxide mediates inhibition of NF-kappa B. J Biol Chem 1995, 270:14214\u201314219.","journal-title":"J Biol Chem"},{"key":"48_CR34","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1161\/hh0801.089861","volume":"88","author":"J. Loscalzo","year":"2001","unstructured":"Loscalzo J: Nitric oxide insufficiency, platelet activation, and arterial thrombosis. Circ Res 2001, 88:756\u2013762.","journal-title":"Circ Res"},{"key":"48_CR35","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1073\/pnas.0237367100","volume":"100","author":"F. de Nigris","year":"2003","unstructured":"de Nigris F, Lerman LO, Ignarro SW, et al.: Beneficial effects of antioxidants and L-arginine on oxidation-sensitive gene expression and endothelial NO synthase activity at sites of disturbed shear stress. Proc Natl Acad Sci U S A 2003, 100:1420\u20131425.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"48_CR36","first-page":"22","volume":"110","author":"G.N. Welch","year":"1998","unstructured":"Welch GN, Upchurch GR, Farivar RS, et al.: Homocysteineinduced nitric oxide production in vascular-smooth muscle cells by NF-kB-dependent transcriptional activation of Nos2. Proc Assoc Am Phys 1998, 110:22\u201331.","journal-title":"Proc Assoc Am Phys"},{"key":"48_CR37","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1172\/JCI118776","volume":"98","author":"J. Loscalzo","year":"1996","unstructured":"Loscalzo J: The oxidant stress of hyperhomocyst(e)inemia. J Clin Invest 1996, 98:5\u20137.","journal-title":"J Clin Invest"},{"key":"48_CR38","doi-asserted-by":"publisher","first-page":"15518","DOI":"10.1074\/jbc.M501452200","volume":"280","author":"D.E. Handy","year":"2005","unstructured":"Handy DE, Zhang Y, Loscalzo J: Homocysteine down-regulates cellular glutathione peroxidase (GPx1) by decreasing translation. J Biol Chem 2005, 280:15518\u201315525.","journal-title":"J Biol Chem"},{"key":"48_CR39","doi-asserted-by":"publisher","first-page":"12503","DOI":"10.1073\/pnas.231428998","volume":"98","author":"N. Weiss","year":"2001","unstructured":"Weiss N, Zhang YY, Heydrick S, et al.: Overexpression of cellular glutathione peroxidase rescues homocyst(e)ineinduced endothelial dysfunction. Proc Natl Acad Sci U S A 2001, 98:12503\u201312508.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"48_CR40","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1161\/01.CIR.98.18.1848","volume":"98","author":"M.F. Bellamy","year":"1998","unstructured":"Bellamy MF, McDowell IF, Ramsey MW, et al.: Hyperhomocysteinemia after an oral methionine load acutely impairs endothelial function in healthy adults. Circulation 1998, 98:1848\u20131852.","journal-title":"Circulation"},{"key":"48_CR41","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1161\/01.CIR.0000134487.51510.97","volume":"110","author":"J. Zhou","year":"2004","unstructured":"Zhou J, Werstuck GH, Lhotak S, et al.: Association of multiple cellular stress pathways with accelerated atherosclerosis in hyperhomocysteinemic apolipoprotein E-deficient mice. Circulation 2004, 110:207\u2013213.","journal-title":"Circulation"},{"key":"48_CR42","first-page":"271","volume-title":"Homocysteine in Health and Disease","author":"R. Carmel","year":"2001","unstructured":"Carmel R: Folate deficiency. In Homocysteine in Health and Disease. Edited by Carmel R, Jacobsen DW. New York: Cambridge University Press; 2001:271\u2013288."},{"key":"48_CR43","first-page":"601","volume-title":"Harrison\u2019s Principles of Internal Medicine","author":"B.M. Babior","year":"2005","unstructured":"Babior BM, Bunn FH: Meagaloblastic anemias. In Harrison\u2019s Principles of Internal Medicine, 16th edition. Edited by Longo DL. New York: McGraw-Hill Press; 2005:601\u2013607.","edition":"16th edition"},{"key":"48_CR44","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1161\/01.ATV.0000092871.30563.41","volume":"23","author":"M.O. Hiltunen","year":"2003","unstructured":"Hiltunen MO, Yia-Herttuala S: DNA methylation, smooth muscle cells, and atherogenesis. Arterioscler Thromb Vasc Biol 2003, 23:1750\u20131753.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"48_CR45","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1056\/NEJMe068060","volume":"354","author":"J. Loscalzo","year":"2006","unstructured":"Loscalzo J: Homocysteine trials-clear outcomes for complex reasons. N Engl J Med 2006, 354:1629\u20131632.","journal-title":"N Engl J Med"},{"key":"48_CR46","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1056\/NEJM199905133401901","volume":"340","author":"P.F. Jacques","year":"1999","unstructured":"Jacques PF, Selhub J, Bostom AG, et al.: The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med 1999, 340:1449\u20131454.","journal-title":"N Engl J Med"},{"key":"48_CR47","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/0140-6736(91)90133-A","volume":"338","author":"MRC Vitamin Study Research Group","year":"1991","unstructured":"MRC Vitamin Study Research Group: Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 1991, 338:131\u2013137.","journal-title":"Lancet"},{"key":"48_CR48","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1146\/annurev.med.49.1.31","volume":"49","author":"H. Refsum","year":"1998","unstructured":"Refsum H, Ueland PM, Nyg\u00e5rd O, Vollset SE: Homocysteine and cardiovascular disease. Annu Rev Med 1998, 49:31\u201362.","journal-title":"Annu Rev Med"},{"key":"48_CR49","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1001\/jama.277.22.1775","volume":"277","author":"I.M. Graham","year":"1997","unstructured":"Graham IM, Daly LE, Refsum HM, et al.: Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA 1997, 277:1775\u20131781.","journal-title":"JAMA"},{"key":"48_CR50","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1056\/NEJM199707243370403","volume":"337","author":"O. Nyg\u00e5rd","year":"1997","unstructured":"Nyg\u00e5rd O, Norderhaug JE, Refsum H, et al.: Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 1997, 337:230\u2013236.","journal-title":"N Engl J Med"},{"key":"48_CR51","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1056\/NEJMoa055373","volume":"355","author":"T.J. Wang","year":"2006","unstructured":"Wang TJ, Gona P, Larson M, et al.: Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med 2006, 355:2631\u20132639.","journal-title":"N Engl J Med"},{"key":"48_CR52","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1001\/jama.288.16.2015","volume":"288","author":"Homocysteine Studies Collaboration","year":"2002","unstructured":"Homocysteine Studies Collaboration: Homocysteine and risk of ischemic heart disease and stroke; a meta-analysis. JAMA 2002, 288:2015\u20132022.","journal-title":"JAMA"},{"key":"48_CR53","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1136\/bmj.325.7374.1202","volume":"325","author":"D.S. Wald","year":"2002","unstructured":"Wald DS, Law M, Morris JK: Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 2002, 325:1202\u20131209.","journal-title":"BMJ"},{"key":"48_CR54","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1056\/NEJMoa011364","volume":"345","author":"G. Schynder","year":"2001","unstructured":"Schynder G, Roffi M, Pin R, et al.: Decreased rate of coronary restenosis after lowering of plasma homocysteine levels. N Engl J Med 2001, 345:1593\u20131600.","journal-title":"N Engl J Med"},{"key":"48_CR55","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/S0002-9149(03)00281-9","volume":"91","author":"G. Schnyder","year":"2003","unstructured":"Schnyder G, Roffi M, Flammer Y, et al.: Effect of homocysteine-lowering therapy on restenosis after percutaneous coronary intervention for narrowings in small coronary arteries. Am J Cardiol 2003, 91:1265\u20131269.","journal-title":"Am J Cardiol"},{"key":"48_CR56","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1056\/NEJMoa032845","volume":"350","author":"H. Lange","year":"2004","unstructured":"Lange H, Surapranata H, De Luca G, et al.: Folate therapy and in-stent restenosis after coronary stenting. N Engl J Med 2004, 350:2673\u20132681.","journal-title":"N Engl J Med"},{"key":"48_CR57","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.jacc.2006.04.086","volume":"48","author":"S. Kaul","year":"2006","unstructured":"Kaul S, Zadeh AA, Shah PK: Homocysteine hypothesis for atherothrombotic cardiovascular disease, not validated. J Am Coll Cardiol 2006, 48:914\u2013923.","journal-title":"J Am Coll Cardiol"},{"key":"48_CR58","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1001\/jama.296.22.2720","volume":"296","author":"L.A. Bazzano","year":"2006","unstructured":"Bazzano LA, Renolds K, Holder KN, He J: Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trials. JAMA 2006, 296:2720\u20132726.","journal-title":"JAMA"},{"key":"48_CR59","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1016\/S0735-1097(03)00485-6","volume":"41","author":"A. Liem","year":"2003","unstructured":"Liem A, Reynierse-Buitenwerf GH, Zwinderman AH, et al.: Secondary prevention with folic acid: effects on clinical outcomes. J Am Coll Cardiol 2003, 41:2105\u20132113.","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl6","key":"48_CR60","doi-asserted-by":"crossref","first-page":"1726S","DOI":"10.1093\/jn\/136.6.1726S","volume":"136","author":"J. Selhub","year":"2006","unstructured":"Selhub J: The many facets of hyperhomocysteinemia: studies from the Framingham cohorts. J Nutr 2006, 136(Suppl 6):1726S\u20131730S.","journal-title":"J Nutr"},{"key":"48_CR61","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1056\/NEJM199104253241701","volume":"324","author":"R. Clarke","year":"1991","unstructured":"Clarke R, Daly L, Robinson K, et al.: Hyperhomocysteinemia and independent risk factor for vascular disease. N Engl J Med 1991, 324:1149\u20131155.","journal-title":"N Engl J Med"},{"key":"48_CR62","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1056\/NEJM197409122911101","volume":"291","author":"L.A. Harker","year":"1974","unstructured":"Harker LA, Slichter SJ, Scott CR, et al.: Homocysteinemia: vascular injury and arterial thrombosis. N Engl J Med 1974, 291:537\u2013541.","journal-title":"N Engl J Med"},{"key":"48_CR63","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1161\/01.RES.53.6.731","volume":"53","author":"L.A. Harker","year":"1983","unstructured":"Harker LA, Harlan JM, Ross R: Effect of sulfinpyrazone on homocysteine-induced injury and atherosclerosis in baboons. Circ Res 1983, 53:731\u2013738.","journal-title":"Circ Res"},{"key":"48_CR64","first-page":"21","volume-title":"Homocysteine in Health and Disease","author":"H. Jakubowski","year":"2001","unstructured":"Jakubowski H: Biosynthesis and reactions of homocysteine thiolactone. In Homocysteine in Health and Disease. Edited by Carmel R, Jacobsen DW. New York: Cambridge University Press; 2001:21\u201331."},{"key":"48_CR65","first-page":"32","volume-title":"Homocysteine in Health and Disease","author":"J.W. Heinecke","year":"2001","unstructured":"Heinecke JW: Unique aspects of sulfur chemistry: homocysteine and lipid oxidation. In Homocysteine in Health and Disease. Edited by Carmel R, Jacobsen DW. New York: Cambridge University Press; 2001:32\u201338."},{"key":"48_CR66","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1093\/ajcn\/84.6.1317","volume":"84","author":"D.T. Villareal","year":"2006","unstructured":"Villareal DT, Miller BV 3rd, Banks M, et al.: Effect of lifestyle intervention on metabolic coronary heart disease risk factors in obese older adults. Am J Clin Nutr 2006, 84:1317\u20131327.","journal-title":"Am J Clin Nutr"},{"key":"48_CR67","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1056\/NEJMoa055317","volume":"355","author":"T.L. Halton","year":"2006","unstructured":"Halton TL, Willett WC, Liu S, et al.: Low-carbohydratediet score and the risk of coronary heart disease in women. N Engl J Med 2006, 355:1991\u20132002.","journal-title":"N Engl J Med"},{"key":"48_CR68","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1161\/CIRCULATIONAHA.105.570846","volume":"113","author":"Q. Yang","year":"2006","unstructured":"Yang Q, Botto LD, Erickson D, et al.: Improvement in stroke mortality in Canada and the United States, 1990\u20132002. Circulation 2006, 113:1335\u20131343.","journal-title":"Circulation"},{"key":"48_CR69","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.atherosclerosis.2005.01.001","volume":"181","author":"M.L. Rasouli","year":"2005","unstructured":"Rasouli ML, Khurram N, Blumenthal RS, et al.: Plasma homocysteine predicts progression of atherosclerosis. Atherosclerosis 2005, 181:159\u2013165.","journal-title":"Atherosclerosis"}],"container-title":["Current Atherosclerosis Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-007-0048-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11883-007-0048-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-007-0048-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-007-0048-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,15]],"date-time":"2022-05-15T22:04:54Z","timestamp":1652652294000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11883-007-0048-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8,29]]},"references-count":69,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["48"],"URL":"https:\/\/doi.org\/10.1007\/s11883-007-0048-x","relation":{},"ISSN":["1523-3804","1534-6242"],"issn-type":[{"value":"1523-3804","type":"print"},{"value":"1534-6242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8,29]]},"assertion":[{"value":"29 August 2007","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}